Skip to main content
SpringerLink
Log in

Einsatz von Cannabinoiden bei chemotherapieinduzierter Übelkeit und Erbrechen

Use of cannabinoids for chemotherapy-induced nausea and vomiting

  • Evidenzbasierte Medizin
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S (2015) Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009464.pub2

    Google Scholar 

  2. Escobar Y, Cajaraville G, Virizuela JA et al (2015) Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. Support Care Cancer 23(9):2833–2840

    Article  PubMed  PubMed Central  Google Scholar 

  3. Haiderali A, Menditto L, Good M et al (2011) Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population. Support Care Cancer 19(6):843–851

    Article  PubMed  Google Scholar 

  4. Schwartzberg L, Morrow G, Balu S et al (2011) Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5‑HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States. Curr Med Res Opin 27(8):1613–1622

    Article  CAS  PubMed  Google Scholar 

  5. Roila F, Herrstedt J, Gralla RJ, Tonato M (2011) Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference. Support Care Cancer 19(Suppl 1):S63–S65

    Article  PubMed  Google Scholar 

  6. Beusterien K, Grinspan J, Kuchuk I et al (2014) Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects. Oncologist 19(2):127–134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Andrews PLR (1992) Physiology of nausea and vomitting. Br J Anaesth 69:2S–19S

    Article  CAS  PubMed  Google Scholar 

  8. Davis MP, Walsh D (2000) Treatment of nausea and vomitting in advanced cancer. Support Care Cancer 8(6):444–452

    Article  CAS  PubMed  Google Scholar 

  9. Freistühler M (2009) Gastrointestinale Symptome. In: Kloke M et al (Hrsg) Grundwissen Palliativmedizin. DÄV, Köln

    Google Scholar 

  10. Jordan K, Gralla R, Jahn F, Molassiotis A (2014) International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice. Eur J Pharmacol 722:197–202

    Article  CAS  PubMed  Google Scholar 

  11. Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189–4198

    Article  PubMed  PubMed Central  Google Scholar 

  12. Roila F, Herrstedt J, Aapro M et al (2011) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232–v243

    Google Scholar 

  13. NCCN Clinical Practice Guidelines in Oncology (2016) Antiemesis (NCCN Guidelines®)

    Google Scholar 

  14. Dronabinol. Arzneimittel-Fachinformation. https://panakeia.ch/

  15. Tramer MR, Carroll D, Campbell FA, Reynolds DJ et al (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323(7303):16–21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2017) Leitlinienprogramm Onkologie: Supportive Therapie bei onkologischen PatientInnen – Langversion 1.1

Download references

Danksagung

UroEvidence dankt Claudia Bollig (Cochrane Deutschland) und Janine Weiberg (DGU) für die Durchsicht und Kommentare zu dieser Übersetzung.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Ernst-Heydemann-Str. 6, 18055, Rostock, Deutschland

    Désirée Louise Dräger

  2. UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Deutschland

    Désirée Louise Dräger

Authors
  1. Désirée Louise Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Désirée Louise Dräger.

Ethics declarations

Interessenkonflikt

D.L. Dräger gibt an, dass kein Interessenkonflikt besteht.

Additional information

Die Zusammenfassung ist eine Übersetzung des Abstracts der Originalpublikation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dräger, D.L. Einsatz von Cannabinoiden bei chemotherapieinduzierter Übelkeit und Erbrechen. Urologe 57, 54–58 (2018). https://doi.org/10.1007/s00120-017-0560-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-017-0560-8

Search

Navigation